Reduced incidence of kaposi's sarcoma and of systemic non‐hodgkin's lymphoma in HIV‐infected individuals treated with highly active antiretroviral therapy

No abstract is available for this paper.

• Publication year

  2003

• Venue

  International Journal of Cancer

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/ijc.10790PMID 12455069
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Impact of Highly Active Antiretroviral Therapy on Individual AIDS‐Defining Illness Incidence and Survival in Australia

  2002cited by this paper
• AIDS and cancer in the era of highly active antiretroviral therapy (HAART).

  2001cited by this paper
• Non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy.

  2001cited by this paper
• Incidence and Trends in Kaposi’s Sarcoma in the Era of Effective Antiretroviral Therapy

  2000cited by this paper
• Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults.

  2000cited by this paper
• AIDS across Europe, 1994-98: the EuroSIDA study.

  2000cited by this paper
• Cancer risk among men with, or at risk of, HIV infection in southern Europe

  2000cited by this paper
• AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study.

  1999cited by this paper
• Effect of antiretroviral therapy on recent trends in selected cancers among HIV-infected persons. Adult/Adolescent Spectrum of HIV Disease Project Group.

  1998cited by this paper

• Advances in the Study of Kaposi’s Sarcoma in Human

  2021cites this paper
• Comparative transcriptome analysis of endemic and epidemic Kaposi’s sarcoma (KS) lesions and the secondary role of HIV-1 in KS pathogenesis

  2020cites this paper
• Poor prognosis of retroperitoneal mixed extragonadal germ cell tumors in an HIV-infected man with severe immunosuppression and bilateral cryptorchidism: a case report

  2019cites this paper
• Treating Kaposi Wounds in the AIDS Patients

  2016cites this paper
• Report on Carcinogens Monograph on Human Immunodeficiency Virus Type 1

  2016influential citation
• Treating Kaposi Wounds in the AIDS

  2016cites this paper
• Kaposi's Sarcoma in HIV‐infected patients in South Africa: Multicohort study in the antiretroviral therapy era

  2014cites this paper
• Age patterns of Kaposi's sarcoma incidence in a cohort of HIV-infected men

  2014cites this paper
• British HIV Association guidelines for HIV‐associated malignancies 2014

  2014cites this paper
• The prevalence of opportunistic infections and malignancies in autopsied patients with human immunodeficiency virus infection in Japan

  2014cites this paper
• Epidemiology and Transmission of Kaposi’s Sarcoma-Associated Herpesvirus

  2014cites this paper
• Classification of AIDS-related lymphoma cases between 1987 and 2012 in Japan based on the WHO classification of lymphomas, fourth edition

  2014influential citation
• Prospective stage-stratified approach to AIDS-related Kaposi's sarcoma.

  2014cites this paper
• British HIV Association guidelines for the treatment of HIV‐1‐positive adults with antiretroviral therapy 2012 (Updated November 2013. All changed text is cast in yellow highlight.)

  2014cites this paper
• Incidence Rate of Kaposi Sarcoma in HIV-Infected Patients on Antiretroviral Therapy in Southern Africa: A Prospective Multicohort Study

  2014cites this paper
• Treatment of severe or progressive Kaposi's sarcoma in HIV-infected adults.

  2014cites this paper
• Treatment of severe or progressive Kaposi's sarcoma in HIV-infected adults.

  2014cites this paper
• Broader implications of a stage-guided stratified therapeutic approach for AIDS-related Kaposi's sarcoma.

  2014cites this paper
• 9.0 Acknowledgements

  2014cites this paper
• 10.0 List of abbreviations

  2014cites this paper
• 7.0 Managing virological failure

  2014cites this paper
• 2.0 Recommendations and auditable outcomes

  2014cites this paper
• 6.0 Supporting patients on therapy

  2014cites this paper
• 4.0 When to start

  2014cites this paper
• 11.0 List of appendices

  2014cites this paper
• 3.0 Patient involvement in decision‐making

  2014cites this paper
• 8.0 Antiretroviral therapy in specific populations

  2014cites this paper
• 1.0 Introduction

  2014cites this paper
• Nutritional Management of Patients Living with HIV and Cancer

  2013cites this paper
• Epidemiology of Malignant Tumors among HIV-infected Population in China

  2013cites this paper
• The interaction between smoking status and highly active antiretroviral therapy (HAART) use on the risk of Kaposi's sarcoma (KS) in a cohort of HIV-infected men

  2013cites this paper
• 4.0 When to start

  2012cites this paper
• iArc monogrAphs on the evAluAtion oF cArcinogenic risks to humAns

  2012cites this paper
• 7.0 Managing virological failure

  2012cites this paper
• 3.0 Patient involvement in decision‐making

  2012cites this paper
• 10.0 List of abbreviations

  2012cites this paper
• 1.0 Introduction

  2012cites this paper
• 11.0 List of appendices

  2012cites this paper
• 9.0 Acknowledgements

  2012cites this paper
• Human and Animal Retroviruses: HIV-1 Infection Is a Risk Factor for Malignancy

  2012cites this paper
• Impact of antiretroviral therapy on the incidence of Kaposi's sarcoma in resource-rich and resource-limited settings

  2012cites this paper
• Rhadinoviruses: KSHV and Associated Malignancies

  2012cites this paper
• 2.0 Recommendations and auditable outcomes

  2012cites this paper
• 8.0 Antiretroviral therapy in specific populations

  2012cites this paper
• Randomized trial of paclitaxel versus pegylated liposomal doxorubicin for advanced human immunodeficiency virus‐associated Kaposi sarcoma

  2010cites this paper
• Cancer: the effects of HIV and antiretroviral therapy, and implications for early antiretroviral therapy initiation

  2009cites this paper
• [Malignancies in HIV infected patients: study of 139 cases].

  2009cites this paper
• Cancer risk in HIV-infected persons: influence of CD4(+) count.

  2009cites this paper
• CD4 counts and the risk of systemic non-Hodgkin’s lymphoma in individuals with HIV in the UK

  2009cites this paper
• Survival After AIDS Diagnosis in Italy, 1999-2006: A Population-Based Study

  2009cites this paper
• Immunotherapy for HIV-associated non-Hodgkin's lymphoma

  2009cites this paper
• Long-term prognosis of HIV-infected patients with Kaposi sarcoma treated with pegylated liposomal doxorubicin.

  2008cites this paper
• HIV-Associated Malignancies

  2008cites this paper
• Effect of HAART on Incident Cancer and Noncancer AIDS Events Among Male HIV Seroconverters

  2008cites this paper
• Symptom Control And Palliative Care Used In Patients Affected By Kaposi Sarcoma In Vryheid Hospital

  2008cites this paper
• Non-Hodgkin lymphoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy

  2008cites this paper
• British HIV Association guidelines for HIV‐associated malignancies 2008

  2008cites this paper
• HIV infection and cancer in the era of highly active antiretroviral therapy (Review).

  2007cites this paper
• A randomized, double-blind study of pegylated liposomal doxorubicin for the treatment of AIDS-related Kaposi's sarcoma.

  2007cites this paper
• Differential impact of combination antiretroviral therapy in preventing Kaposi's sarcoma with and without visceral involvement.

  2006cites this paper
• [Diffuse large B-cell lymphoma].

  2006cites this paper
• Capítulo 30 – Manifestaciones dermatológicas de las neoplasias internas

  2006cites this paper
• Linfoma B difuso de células grandes

  2006cites this paper
• Linfoma primario de cavidades

  2006cites this paper
• Decrease in Epstein-Barr virus-positive AIDS-related lymphoma in the era of highly active antiretroviral therapy.

  2006cites this paper
• Changing incidence and prognostic factors of survival in AIDS-related non-Hodgkin's lymphoma in the era of highly active antiretroviral therapy (HAART)

  2005cites this paper
• Treatment of HIV-1-Associated Kaposi’s Sarcoma with Pegylated Liposomal Doxorubicin and HAART Simultaneously Induces Effective Tumor Remission and CD4+ T Cell Recovery

  2005cites this paper
• Treatments of AIDS-related Kaposi's sarcoma.

  2005cites this paper
• Interactions Between Antiretrovirals and Antineoplastic Drug Therapy

  2005cites this paper
• Highly active antiretroviral therapy in AIDS-associated Kaposi's sarcoma: implications for the design of therapeutic trials in patients with advanced, symptomatic Kaposi's sarcoma.

  2004cites this paper
• Highly active antiretroviral therapy in AIDS-associated Kaposi's sarcoma (KS): implications for the design of therapeutic trials in patients with advanced symptomatic KS.

  2004cites this paper
• Cutaneous Plasmablastic Lymphoma in an HIV-Positive Male: An Unrecognized Cutaneous Manifestation

  2004cites this paper
• Current treatment strategies for patients with Hodgkin’s lymphoma and HIV infection

  2004cites this paper
• Cholestasis in HIV-infected patients.

  2004cites this paper
• Lung cancer in patients with HIV infection: is it AIDS‐related?

  2004cites this paper
• [Lymphomas in patients with HIV infection. A change for the better].

  2004cites this paper
• Antitumour effects of antiretroviral therapy

  2004cites this paper
• Linfomas en pacientes con infección por el VIH. Las cosas han cambiado para bien

  2004cites this paper
• Clinical Characteristics of Gastrointestinal Lymphomas Associated with AIDS (GI-ARL) and the Impact of HAART

  2004cites this paper
• Treatment options in chronic myeloid leukemia: imatinib vs interferon

  2004cites this paper
• Lymphoma : Burkitt lymphoma 401

  2003cites this paper
• Incidence of AIDS-Defining Cancers After AIDS Diagnosis Among People with AIDS in Italy, 1986–1998

  2003cites this paper
• Is HIV involved in the pathogenesis of non-infectious pulmonary complications in infected patients?

  2003cites this paper